gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
A method for treating a disease using a specific compound.
|
gptkbp:applicationNumber
|
10/123,456
|
gptkbp:applicationType
|
utility
|
gptkbp:assignee
|
gptkb:ABC_Corporation
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:clinicalTrials
|
Phase II
NCT01234567
|
gptkbp:coInventor
|
Jane_Smith
|
gptkbp:composedOf
|
chemical synthesis
|
gptkbp:dosageForm
|
tablet
|
gptkbp:examiner
|
gptkb:Dr._Richard_Roe
|
gptkbp:expirationDate
|
2024-01-30
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
gptkbp:filingDate
|
2004-01-30
|
gptkbp:grantDate
|
2004-09-14
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,064 C61
|
gptkbp:internationalClassification
|
A61K
|
gptkbp:inventiveStep
|
non-obviousness
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:issueDate
|
2004-09-14
|
gptkbp:legalStatus
|
granted
|
gptkbp:maintenanceFee
|
paid
|
gptkbp:marketedAs
|
CancerX
|
gptkbp:material
|
Compound X
|
gptkbp:novelty
|
new compound
|
gptkbp:patentAbstract
|
A method for treating a disease using a specific compound.
|
gptkbp:patentAssignee
|
gptkb:ABC_Corporation
|
gptkbp:patentCitation
|
10
|
gptkbp:patentClassification
|
A61K 31/00
|
gptkbp:patentExpiration
|
2024-01-30
|
gptkbp:patentFamily
|
US_6,789,064_C61,_EP_1234567,_JP_2004-123456.
|
gptkbp:patentField
|
pharmaceuticals
|
gptkbp:patentFilingDate
|
2004-09-14
2004-01-30
|
gptkbp:patentInventor
|
gptkb:John_Doe
|
gptkbp:patentLitigation
|
none
|
gptkbp:patentNumber
|
6,789,064
|
gptkbp:patentType
|
granted patent
|
gptkbp:priorityDate
|
2003-01-30
|
gptkbp:publicationNumber
|
2004/0123456 A1
|
gptkbp:relatedTo
|
gptkb:US_6,123,456_C1
|
gptkbp:research_areas
|
oncology
treatment of cancer
|
gptkbp:researchField
|
oncology
|
gptkbp:researchInterest
|
gptkb:XYZ_Research_Institute
|
gptkbp:route
|
oral
|
gptkbp:sideEffect
|
nausea
|
gptkbp:status
|
active
|
gptkbp:territory
|
gptkb:United_States
|
gptkbp:title
|
Method for treating a disease
|